Nea-Management-Company

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
38
Total Value
1298444752
Accession Number
0000897069-25-000979
Form Type
13F-HR
Manager Name
Nea-Management-Company
Data Enrichment
97% identified
37 identified1 unidentified

Holdings

38 positions • $1.3B total value
Manager:
Search and click to pin securities to the top
Page 1 of 2
Arcellx, Inc.
Shares:3.7M
Value:$245.7M
% of Portfolio:18.9% ($245.7M/$1.3B)
Verona Pharma plc
Shares:2.7M
Value:$170.7M
% of Portfolio:13.1% ($170.7M/$1.3B)
RHYTHM PHARMACEUTICALS, INC.
Shares:2.9M
Value:$154.1M
% of Portfolio:11.9% ($154.1M/$1.3B)
Tempus AI, Inc.
Shares:2.6M
Value:$126.2M
% of Portfolio:9.7% ($126.2M/$1.3B)
Coursera, Inc.
Shares:12.9M
Value:$85.7M
% of Portfolio:6.6% ($85.7M/$1.3B)
Trevi Therapeutics, Inc.
Shares:11.4M
Value:$71.5M
% of Portfolio:5.5% ($71.5M/$1.3B)
Savara Inc
Shares:24.5M
Value:$67.8M
% of Portfolio:5.2% ($67.8M/$1.3B)
CRISPR Therapeutics AG
Shares:1.6M
Value:$54.0M
% of Portfolio:4.2% ($54.0M/$1.3B)
Monte Rosa Therapeutics, Inc.
Shares:7.7M
Value:$35.7M
% of Portfolio:2.7% ($35.7M/$1.3B)
Aurinia Pharmaceuticals Inc.
Shares:4.0M
Value:$31.9M
% of Portfolio:2.5% ($31.9M/$1.3B)
MBX Biosciences, Inc.
Shares:3.6M
Value:$26.7M
% of Portfolio:2.1% ($26.7M/$1.3B)
CVRx, Inc.
Shares:2.0M
Value:$24.8M
% of Portfolio:1.9% ($24.8M/$1.3B)
Zenas BioPharma, Inc.
Shares:2.6M
Value:$20.7M
% of Portfolio:1.6% ($20.7M/$1.3B)
Gossamer Bio, Inc.
Shares:18.1M
Value:$19.9M
% of Portfolio:1.5% ($19.9M/$1.3B)
Korro Bio, Inc.
Shares:1.1M
Value:$19.0M
% of Portfolio:1.5% ($19.0M/$1.3B)
NeueHealth, Inc.
Shares:2.7M
Value:$18.4M
% of Portfolio:1.4% ($18.4M/$1.3B)
CHAMPIONS ONCOLOGY, INC.
Shares:1.7M
Value:$14.9M
% of Portfolio:1.1% ($14.9M/$1.3B)
Senti Biosciences, Inc.
Shares:3.8M
Value:$12.7M
% of Portfolio:1.0% ($12.7M/$1.3B)
Celcuity Inc.
Shares:1.3M
Value:$12.6M
% of Portfolio:1.0% ($12.6M/$1.3B)
Phathom Pharmaceuticals, Inc.
Shares:2.0M
Value:$12.3M
% of Portfolio:0.9% ($12.3M/$1.3B)